For this reason, the expression of FADS1 and FADS2 is increased in some cancers, e.g., Lewis lung carcinoma [35], melanoma [35], colon cancer [36], hepatocellular carcinoma [37], and breast cancer [34]. Here, FADS2 is linked to melanoma.